Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AKTS compared with HMH: revenue, margins and what each company keeps, and the suppliers and customers both name
AKTS
Aktis Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
HMH
HMH Holding Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
AKTS
Aktis Oncology, Inc.
vs
HMH
HMH Holding Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
AKTS: latest quarter is a loss; flow not drawable. HMH: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AKTS, solid
HMH, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: AKTS, HMH.
Role chip = supplier or customer
Source: SEC EDGAR
AKTS
Aktis Oncology, Inc.
Change
15.96
▼
−5.31%
· post 15.96
Mkt cap
$880.9M
Revenue
$3M
Q2 FY26
HMH
HMH Holding Inc
Change
18.79
▲
+0.63%
· post 18.79
Closed
Oct 30 '26
Mkt cap
—
Revenue
$171M
Q2 FY26
vs
Compare
Closed
Oct 30 '26
AKTS
Aktis Oncology, Inc.
vs
HMH
HMH Holding Inc
15.96
▼
−5.31%
post 15.96
Price
18.79
▲
+0.63%
post 18.79
$880.9M
Mkt cap
—
Q2 FY26
$3M
Revenue
$171M
Q2 FY26
Change
Change
AKTS
15.96
▼
−5.31%
vs
HMH
18.79
▲
+0.63%
Closed
Oct 30 '26